Jose Seijas-Amigo

5PUBLICATIONS
10CO-AUTHORS
Preventative health carePharmacogenomicsToxicology (incl. clinical toxicology)Clinical chemistry (incl. diagnostics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2026
Cardiovascular health as an unmet priority in addiction medicine: Implications of recent cardiovascular strategies.

|Jul 06, 2026
Addiction as a cardiometabolic disease: a neurocardiometabolic framework and the emerging role of GLP-1 receptor therapies.

|Feb 25, 2026
Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System.

Jose Seijas-Amigo, Ángel Salgado-Barreira, Diego Rodriguez-Penas

|Oct 25, 2024
Cost-Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study.

José Seijas-Amigo, Maria José Mauriz-Montero, Pedro Suarez-Artime

|Aug 23, 2023
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World-MEMOGAL Study.

Jose Seijas-Amigo, Mª José Mauriz-Montero, Pedro Suarez-Artime

Pageof 1

Frequent Collaborators

1 joint publications

Pedro Suarez-Artime

1 joint publications

Mónica Gayoso-Rey

1 joint publications

Francisco Reyes-Santías

1 joint publications

Ana Estany-Gestal